CIK 0001716166 · Non-accelerated filer<br>Smaller reporting company
Vivos Therapeutics, Inc.
Sign in to watch- Ticker
- VVOS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 813224056
- Phone
- (866)908-4867
- Business address
- 7921 SOUTHPARK PLAZA,, SUITE 210, LITTLETON, CO, 80120
- Former names
- Vivos BioTechnologies, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-01 | Huntsman Ronald Kirk Chief Executive Officer | Purchase | +4,000 | $1.83 | $7K | 27,500 |
| 2022-05-31 | Huntsman Ronald Kirk Chief Executive Officer | Purchase | +8,000 | $2.03 | $16K | 23,500 |
| 2022-02-25 | Huntsman Ronald Kirk Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | $3.27 | $409K | 125,000 |
| 2022-02-25 | Amman Bradford K. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | $3.27 | $164K | 50,000 |
| 2021-09-21 | Huntsman Ronald Kirk Chief Executive Officer | Purchase | +5,000 | $4.31 | $22K | 15,500 |
| 2021-08-31 | Amman Bradford K. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | $5.26 | $263K | 50,000 |
| 2021-08-17 | Huntsman Ronald Kirk Chief Executive Officer | Purchase | +5,000 | $3.00 | $15K | 10,500 |
| 2021-08-05 | Thompson Matthew Director | Grant or award · Stock Option (Right to Buy) | +30,000 | $2.72 | $82K | 46,667 |
| 2021-08-05 | Green Ralph Elias Director | Grant or award · Stock Option (Right to Buy) | +30,000 | $2.72 | $82K | 46,667 |
| 2021-08-05 | Krammer Anja B Director | Grant or award · Stock Option (Right to Buy) | +30,000 | $2.72 | $82K | 46,667 |
| 2021-08-05 | Singh Gurdev Dave Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +30,000 | $2.72 | $82K | 46,667 |
| 2021-08-05 | Lindsay Mark F. Director | Grant or award · Stock Option (Right to Buy) | +30,000 | $2.72 | $82K | 46,667 |
| 2021-08-05 | SOKOLOW LEONARD J Director | Grant or award · Stock Option (Right to Buy) | +30,000 | $2.72 | $82K | 46,667 |
| 2021-05-25 | Amman Bradford K. Chief Financial Officer | Purchase | +1,000 | $5.29 | $5K | 2,000 |
| 2021-05-25 | Huntsman Ronald Kirk Chief Executive Officer | Purchase | +4,000 | $5.38 | $22K | 5,500 |
| 2021-03-12 | Amman Bradford K. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | $7.50 | $750K | 100,000 |
| 2021-03-12 | Amman Bradford K. Chief Financial Officer | Grant or award · Stock Option | +100,000 | $7.50 | $750K | 200,001 |
| 2020-12-24 | Amman Bradford K. Chief Financial Officer | Purchase | +1,000 | $7.38 | $7K | 1,000 |
| 2020-12-23 | Huntsman Ronald Kirk Chief Executive Officer | Purchase | +1,000 | $7.27 | $7K | 1,500 |
| 2020-12-11 | Huntsman Ronald Kirk Chief Executive Officer | Purchase | +500 | $8.50 | $4K | 500 |
Page 3 of 4 · 62 trades